Homepage European Medicines Agency
For ease of analysis, keep the type of moving average consistent across the ribbon—for example, use only exponential moving averages or simple moving averages. It is also compulsory for advanced-therapy medicines such as gene-therapy, somatic cell-therapy or tissue-engineered medicines and for orphan medicines (for rare diseases). The centralised procedure is also open to products that…